- Home
- MDXG vs FPF Comparison
MDXG vs FPF Comparison
Compare MDXG & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- FPF
- Stock Information
- Founded
- MDXG 2006
- FPF 2013
- Country
- MDXG United States
- FPF United States
- Employees
- MDXG N/A
- FPF N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- FPF Trusts Except Educational Religious and Charitable
- Sector
- MDXG Health Care
- FPF Finance
- Exchange
- MDXG Nasdaq
- FPF Nasdaq
- Market Cap
- MDXG 1.3B
- FPF 1.1B
- IPO Year
- MDXG N/A
- FPF N/A
- Fundamental
- Price
- MDXG $8.86
- FPF $18.57
- Analyst Decision
- MDXG Strong Buy
- FPF
- Analyst Count
- MDXG 5
- FPF 0
- Target Price
- MDXG $12.00
- FPF N/A
- AVG Volume (30 Days)
- MDXG 573.7K
- FPF 186.7K
- Earning Date
- MDXG 02-26-2025
- FPF 01-01-0001
- Dividend Yield
- MDXG N/A
- FPF 8.08%
- EPS Growth
- MDXG N/A
- FPF N/A
- EPS
- MDXG 0.52
- FPF N/A
- Revenue
- MDXG $342,804,000.00
- FPF N/A
- Revenue This Year
- MDXG $9.56
- FPF N/A
- Revenue Next Year
- MDXG $9.19
- FPF N/A
- P/E Ratio
- MDXG $17.41
- FPF N/A
- Revenue Growth
- MDXG 10.93
- FPF N/A
- 52 Week Low
- MDXG $5.47
- FPF $13.91
- 52 Week High
- MDXG $10.14
- FPF $18.09
- Technical
- Relative Strength Index (RSI)
- MDXG 44.99
- FPF 57.51
- Support Level
- MDXG $8.50
- FPF $18.48
- Resistance Level
- MDXG $9.36
- FPF $18.78
- Average True Range (ATR)
- MDXG 0.27
- FPF 0.18
- MACD
- MDXG -0.02
- FPF 0.07
- Stochastic Oscillator
- MDXG 34.88
- FPF 75.57
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest
First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.